Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Cancer Prev Res (Phila). 2013 Jul 15;6(9):959–970. doi: 10.1158/1940-6207.CAPR-13-0087

Figure 3. Inhibition of the activation of ErbB family receptors by BXL0124, CDDO-Im and the combination on MMTV-ErbB2/neu mammary tumors.

Figure 3

Six tumors from each group were randomly selected based on similar sizes and analyzed as individual tumors (left panel). These six individual tumors from each group were combined as a single pooled sample (right panel). Protein levels of pErbB2, ErbB2, pErbB1, ErbB1, pErbB3 and ErbB3 were determined by Western blot analysis. β-Actin was used as a loading control. For the pooled samples (right panel), quantitation of Western blots was performed by Image J 1.44p (NIH), and the numbers are provided at the bottom of each Western blot.